Here, we have described upstream mechanisms of YAP/TAZ activation in (tumor) ECs and provided an overview of the downstream transcriptional effectors of YAP/TAZ that participate in the development of tumor vasculature. This evidence concerns the gene WWTR1 and neoplasm.